Becton Dickinson gains FDA OK for two-pronged smallpox vaccine needle:
This article was originally published in Clinica
Executive Summary
Becton Dickinson has gained US FDA 510(k) clearance for its bifurcated, two-pronged needle for the delivery of the smallpox vaccine. The needle is designed to aid in the preparation for mass immunisation against the disease, in the event of a bioterrorist threat, said the Franklin Lakes, New Jersey firm. The company is also developing a "safety-engineered" version of the product to help prevent needlestick injuries.